IMPORTANCE Failure of bone fracture healing occurs in 5% to 10% of all patients. Nonunion risk is associated with the severity of injury and with the surgical treatment technique, yet progression to nonunion is not fully explained by these risk factors.
T he rate of fracture nonunion is estimated to be between 5% 1 and 10%, 2 and the rate of nonunion may be increasing as the survival rate for patients with severe injuries improves. 3 The risk of nonunion is related to the severity of injury resulting in fracture, 4 and many randomized clinical trials 5 have shown that variations in nonunion rates are associated with different surgical treatments. However, progression to nonunion is not fully explained by these factors alone. 6 Determination of the probability for and potential mitigation of nonunion risk is an important clinical objective because patients with nonunion can expect more long-term pain, physical disability, mental health problems, and medical treatment costs as well as a slower return to normal work productivity. 7 Herein, we describe the epidemiology of fracture nonunion in adults, with a focus on information available to the clinician at patient presentation. We hypothesize that the interplay between a patient's physiologic risk factors and fracture characteristics increases the risk of fracture nonunion. 5 We tested this hypothesis in a large payer database of patients with fracture in the United States. 8 
Methods

Database
Truven Health Analytics (Durham, North Carolina) compiled patient-level health claims data for medical and drug expenses, together with laboratory test results, hospital discharge information, and death data on 90.1 million patients. 9 Data were submitted by hospitals, managed care
organizations, Medicare and Medicaid programs, and approximately 300 large corporations in exchange for benchmark reports. 9 This study was approved and exempted from the need for informed consent by the institutional review board of Duke University Medical Center because patient data were deidentified. The final database contained 1 row per unique fracture, with comma-separated values for patient variables. Variables included patient demographics, treatment procedures as per the Current Procedural Terminology codes; disease comorbidities as per the International Classification of Diseases, Ninth Revision (ICD-9) codes; and drug prescriptions as per National Drug Code Directory (https://www.accessdata.fda.gov/scripts /cder/ndc/) codes.
Study Design
Study inclusion was limited to patients with a coded bone fracture in calendar year 2011. Patients were excluded if they had less than 12 months of continuous enrollment following fracture so as to capture all coded nonunions.
Fractures were identified based on 5-digit ICD-9 codes. Rule-out codes were not counted; such codes are used to order radiography in some patients who may not have a fracture. In addition, codes with an unspecified character string in the definition were not used because such codes are replaced with a specific code defining the location of the fracture. Nonunion was determined by the presence of either a nonunion code or a code for prescription use of an electrical bone stimulation device since such devices are used to treat nonunion. Patients who used low-intensity pulsed ultrasound devices for a fresh fracture were excluded because this prescription device may increase the healing rate for bone.
Disease comorbidities were identified using ICD-9 primary disease codes. Secondary conditions arising from a chronic disease condition (eg, diabetic retinopathy) were not used as proxies for the primary disease because of the risk of double counting. Thus, our analysis would not identify patients with diabetes diagnosed before 2011, although medications used to treat diabetes would be captured. Medications were identified using National Drug Code Directory codes, which are for oral medications purchased in a retail pharmacy. Such codes contain a range of medications; the opioid class contains analgesics but can also contain opioid agonists used to treat addiction. Medications were assumed to be part of long-term therapy, with the exception of antibiotics, thrombolytics, analgesics, and corticosteroids.
Analysis focused on the cohort of patients aged 18 to 63 years at the time of the fracture. This age range was chosen because skeletal maturity is achieved by approximately 18 years. 10 Patients younger than 18 years were abundant in the database, but their healing rate was high, so it was less compelling to identify risk factors for those who failed to heal. Patients older than 63 years were excluded because the requirement for 12 months of continuous enrollment created an artifact as patients transitioned to Medicare and no longer appeared in the database. Older individuals were also excluded because only some purchase Medicare supplemental coverage and thus are not representative of other Medicare patients.
Analytic Strategy
Our overall hypothesis was that the probability of fracture nonunion can be determined with the use of risk factors derived from patient demographics, using Current Procedural Terminology, ICD-9, and National Drug Code Directory codes. Possible risk factors for nonunion were identified in a literature search, 5 with a focus on risk factors likely to be of concern to orthopedic surgeons. We requested information on 257 potential nonunion risk factors, including fracture type, fracture cause, patient demographics, and medication use. We focused on 18 bones most frequently fractured. An operative treatment variable was defined for patients who received any fracture surgery and we compared them with patients who did not undergo surgery. Statistical analyses were performed using SAS, version 9.4 (SAS Institute Inc). The critical value for significance was set at P < .05. Because so many variables were available for each patient, it was important to group variables into manageable categories. Ultimately, data were pooled to obtain 45 variables of interest (eAppendix in the Supplement). For example, patients had as many as 15 separate fractures, but we binned them into a smaller number of categories for analysis (eg, 1-2 fractures, 3-5 fractures, and ≥6 fractures). Multivariate logistic regression was used to control for correlations among the various risk factors.
We did not adjust for multiple comparisons because showing 95% CIs for each odds ratio (OR) achieves the same end. Furthermore, an OR significant at P < .001 is comparable to an OR significant at P = .05 that has been Bonferroni corrected for 50 comparisons. Correcting for additional comparisons would be likely to lead to type II (false-negative) errors. In an exploratory context such as this, P values should be interpreted as a measure of statistical evidence rather than a test of hypothesis.
Validation
In parallel to the logistic regression analysis, we also conducted random forest decision tree modeling using the same covariates. 11 The random forest method is invariant to interactions and terms of higher dimension, such as quadratic terms. The random forest method generally performs better than regression methods but, unlike regression analysis, is harder to interpret. We compared the methods using the C statistic (area under the receiver operating characteristic curve) and found that the models were substantially equivalent; the C statistic of the random forest model was only slightly larger than the C statistic of the logistic regression model, differing in the third or fourth decimal place. We elected to report only the main effects logistics regression model herein. Nonunion rates for individual bones were also compared with those in the literature. Data analysis was performed from January 1, 2011, to December 31, 2012.
Results
A flowchart (eFigure in the Supplement) shows how the patient sample was assembled. Table 2 ). The number of risk factors and the complex interactions possible between risk factors may explain the absence of multivariate ORs higher than 1.58 ( Table 2) . Use of certain medications increased the nonunion risk ( Table 3) . After controlling for confounding variables, the most powerful risk factor was use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids (multivariate OR, 1.84; 95% CI, 1.73-1.95). Other pain medications, such as opioids alone, and anticonvulsants, with or without benzodiazepines, were moderately strong positive risk factors, whereas antidiabetics other than insulin (OR, 0.92; 95% CI, 0.86-0.99) and oral contraceptives (OR, 0.88; 95% CI, 0.81-0.95) were inversely associated with nonunion.
Nonunion ORs were significantly increased for many risk factors ( Table 4 and Relatively few risk factors affected multiple bones (Tables 4  and 5 ). The need for operative treatment was associated with nonunion in 15 bones, anticoagulant use was associated with nonunion in 14 bones, use of analgesics (NSAIDs and opioids) affected 12 bones, and osteoarthritis and use of anticonvulsants each affected 11 bones. Overall, the largest risk factor for nonunion was the number of fractures (OR, 2.65; 95% CI, 2.34-2.99).
A limited number of putative risk factors were inversely correlated with nonunion (Tables 4 and 5 ), including oral contraceptive use (OR, 0.88; 95% CI, 0.81-0.95), allergy (OR, 0.90; 95% CI, 0.86-0.93), and age (OR, 0.97; 95% CI, 0.95-0.98); each was apparently protective in at least 2 bones. Some bones have several protective factors; both radius and ankle had 3 protective factors. A total of 12 bones had at least 1 protective factor.
Smoking was not identified as a major risk factor in this study (Tables 4 and 5 ). However, our data included only diagnosed past or current smoking, which most reliably may mean that someone was offered smoking cessation therapy. Thus, our count of smokers is likely an underestimate. Only 10.2% of patients were coded as past or current smokers (Table 1) , whereas 18% of the general population is expected to smoke 12 and other nonunion cohort studies have reported a prevalence of smoking higher than the US average. 13 Similarly, we may underestimate obesity prevalence; only diagnosed obesity was analyzed, so many people with nonunion fractures may have been obese but we have no record of it. Lack of convergence of the model was a rare problem (Tables 4 and 5 ) except for coagulants, which appear to be rarely used among patients with fractures ( Table 3) . The number of patients with multiple scaphoid fractures may have been too small to find a solution for nonunion associated with multiple fractures. Only 10 bone-risk factor ORs other than coagulants could not be estimated.
Discussion
There were clear demographic differences between patients whose fractures healed and those whose fractures failed to heal (Table 1) . Most risk factors conferred a relatively small increase in multivariate nonunion risk (Table 2) , perhaps because there are complex interactions between and among risk factors. Use of certain medications was an important determinant of nonunion (Table 3 ). Adjusting medication use by patients may enable physicians to improve the odds that a patient will heal. Nonunion rates varied among bones, and the contributions of various risk factors showed a complex interplay (Tables 4 and 5 ). In general, nonunion rate appears to be a function of fracture severity, fracture location, disease comorbidity, and medication use.
The distinction between univariate and multivariate ORs is important. For example, type 2 diabetes was associated with a univariate OR of 1.60 and a multivariate OR of 1.15 ( Table 2 ).
If that diagnosis is the only information that a clinician has about a patient, then it is reasonable to conclude that this patient has a 1.60-fold higher risk of nonunion than does a person without type 2 diabetes. As other variables become known and can be incorporated into a risk assessment, the risk associated specifically with type 2 diabetes decreases. In a multivariate analysis, which controls for many other factors, the nonunion risk associated with type 2 diabetes was 1.15-fold times the risk of nonunion in a person without that disease (Table 2) . It is almost certainly the case that type 2 diabetes has not been diagnosed and treatment has not been instituted in some patients; thus, the disease would not have been analyzed in this study. Diabetes medications other than insulin appear to provide protection from nonunion (Tables 4 and 5 ), although the mechanism of such a protective effect is not known. When working with large patient databases (eg, big data), unanticipated associations are likely to be found. Causality cannot be tested without using an experimental approach; therefore, big data projects should be regarded as an opportunity for hypothesis generation rather than hypothesis testing.
The overall nonunion rate that we report was 4.9% (Table 1 ). This rate is somewhat lower than others reported in the literature, 1,2 although the healing rate for individual bones aligns well with previously published information. For example, the tibial nonunion rate we report was 7.4% for 12 808 fractures. The literature suggests that the expected nonunion rate for tibial fractures is 7.6%, a value derived by collating the reported healing rate in 46 publications spanning the period from 1976 to 2014 and including 5920 fractures treated This research has several limitations. First, Truven Health Analytics is a payer database that excludes unemployed or indigent patients who might have had a higher rate of nonunion. Second, some diagnoses may have been coded incorrectly as fracture if coding was performed before radiographic imaging. However, this error is unlikely because rule-out codes were not counted; such codes are used to order imaging if a fracture is suspected. Third, some fractures that received treatment in 2011 could have occurred earlier. Fourth, uncoded patient data cannot contribute to conclusions. Data were more likely to be missing from the database if information was not crucial to reimbursement; smokers not receiving medication for smoking cessation would likely not be coded as smokers. Nevertheless, missing data are a problem in every study, including randomized clinical trials. Therefore, we used statistical methods, including random forest analysis, that are robust and resilient despite missing data. 11 Additional limitations are characteristic of claims databases in general; there is imprecision in ICD-9 coding schemes, 72 and coding errors are common but are assumed to distribute randomly and to be minimized by the need for accurate reporting for claims reimbursement and by legal penalties for fraudulent reporting. 73 Limitations do not appear to be a substantial issue because the nonunion rates we report are similar to others in the literature. An important strength of this research is that it has contributed novel insights into the cause of fracture nonunion. For example, use of certain medications is a key risk factor for fracture nonunion (Table 3) . Because medication use is a modifiable risk factor, our findings suggest that clinicians could counsel patients about use of medications. Other strengths of this research are that all data were collected prospectively, the 12-month follow-up time represents a longer follow-up interval 
